San Francisco startup Composition Therapeutics is usually engaged on an oral, at the time-day-to-day GLP-one drug named GSBR-1290—the drug surpassed Wall Street’s expectations in June when a mid-phase review showed common weight loss of about six% and it strategies to start another m